Post-earnings recap
Reported
Mon, Feb 9, 2009
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported a loss per share of $0.19, but no revenue figures were provided. The stock reacted negatively, dropping 4.82%. The lack of additional commentary or guidance may leave investors uncertain about the company's future direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.19 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based solely on numerical results.